WO1998027058A3 - N-piperazin-1-ylphenyl-benzamide derivatives - Google Patents

N-piperazin-1-ylphenyl-benzamide derivatives Download PDF

Info

Publication number
WO1998027058A3
WO1998027058A3 PCT/EP1997/007160 EP9707160W WO9827058A3 WO 1998027058 A3 WO1998027058 A3 WO 1998027058A3 EP 9707160 W EP9707160 W EP 9707160W WO 9827058 A3 WO9827058 A3 WO 9827058A3
Authority
WO
WIPO (PCT)
Prior art keywords
ylphenyl
piperazin
benzamide derivatives
derivatives
benzamide
Prior art date
Application number
PCT/EP1997/007160
Other languages
French (fr)
Other versions
WO1998027058A2 (en
Inventor
Steven Mark Bromidge
Francis David King
Paul Adrian Wyman
Original Assignee
Smithkline Beecham Plc
Steven Mark Bromidge
Francis David King
Paul Adrian Wyman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9626376.9A external-priority patent/GB9626376D0/en
Priority claimed from GBGB9700902.1A external-priority patent/GB9700902D0/en
Application filed by Smithkline Beecham Plc, Steven Mark Bromidge, Francis David King, Paul Adrian Wyman filed Critical Smithkline Beecham Plc
Priority to EP97954435A priority Critical patent/EP0946551A2/en
Priority to JP52734898A priority patent/JP2001506995A/en
Priority to CA002274055A priority patent/CA2274055A1/en
Publication of WO1998027058A2 publication Critical patent/WO1998027058A2/en
Publication of WO1998027058A3 publication Critical patent/WO1998027058A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2

Abstract

Novel carboxamide derivatives having CNS activity, processes for their preparation and their use as medicaments.
PCT/EP1997/007160 1996-12-19 1997-12-15 N-piperazin-1-ylphenyl-benzamide derivatives WO1998027058A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP97954435A EP0946551A2 (en) 1996-12-19 1997-12-15 N-piperazin-1-ylphenyl-benzamide derivatives
JP52734898A JP2001506995A (en) 1996-12-19 1997-12-15 N-piperazin-1-ylphenyl-benzamide derivatives
CA002274055A CA2274055A1 (en) 1996-12-19 1997-12-15 N-piperazin-1-ylphenyl-benzamide derivatives

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB9626376.9A GB9626376D0 (en) 1996-12-19 1996-12-19 Novel compounds
GB9626376.9 1996-12-19
GBGB9700902.1A GB9700902D0 (en) 1997-01-17 1997-01-17 Novel compounds
GB9700902.1 1997-01-17

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US09331353 A-371-Of-International 1999-06-18
US66695700A Continuation 1996-12-19 2000-09-20

Publications (2)

Publication Number Publication Date
WO1998027058A2 WO1998027058A2 (en) 1998-06-25
WO1998027058A3 true WO1998027058A3 (en) 1998-08-20

Family

ID=26310680

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/007160 WO1998027058A2 (en) 1996-12-19 1997-12-15 N-piperazin-1-ylphenyl-benzamide derivatives

Country Status (4)

Country Link
EP (1) EP0946551A2 (en)
JP (1) JP2001506995A (en)
CA (1) CA2274055A1 (en)
WO (1) WO1998027058A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998047885A1 (en) * 1997-04-18 1998-10-29 Smithkline Beecham Plc A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
HUP0003073A3 (en) 1997-07-11 2002-10-28 Smithkline Beecham Plc Benzenesulfonamide derivatives, process for producing them and their use as medicines
GB9803411D0 (en) * 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds
US6194410B1 (en) 1998-03-11 2001-02-27 Hoffman-La Roche Inc. Pyrazolopyrimidine and pyrazolines and process for preparation thereof
CA2340952C (en) * 1998-09-10 2009-12-08 F. Hoffmann-La Roche Ag Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
GB9820113D0 (en) 1998-09-15 1998-11-11 Merck Sharp & Dohme Therapeutic agents
NZ517865A (en) * 1999-09-25 2003-11-28 Smithkline Beecham P Piperazine derivatives as 5-HT1B antagonists
WO2002051397A1 (en) 2000-12-22 2002-07-04 Ishihara Sangyo Kaisha, Ltd. Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
NZ535574A (en) 2001-01-16 2006-07-28 Astrazeneca Ab Therapeutic heterocyclic compounds
MXPA03006268A (en) 2001-01-16 2003-09-22 Astrazeneca Ab Therapeutic chromone compounds.
GB0106586D0 (en) * 2001-03-16 2001-05-09 Smithkline Beecham Plc Novel compounds
SE0103644D0 (en) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic isoquinoline compounds
CA2794153C (en) 2010-03-25 2018-01-02 Glaxosmithkline Llc Substituted indoline derivatives as perk inhibitors

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533267A1 (en) * 1991-09-18 1993-03-24 Glaxo Group Limited Benzanilide derivatives as 5-HT1D antagonists
EP0533266A1 (en) * 1991-09-18 1993-03-24 Glaxo Group Limited Benzanilide derivatives as 5-HT1D antagonists
WO1994001556A1 (en) * 1992-07-01 1994-01-20 Institut National De La Sante Et De La Recherche Medicale (Inserm) Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof
FR2699533A1 (en) * 1992-12-21 1994-06-24 Mouhtaram Mohamed N-2-piperazinyl 4-amino:benzamide derivs. having antiemetic and antipsychotic activity
GB2273930A (en) * 1992-12-30 1994-07-06 Glaxo Group Ltd Benzanilide derivatives
WO1994015920A1 (en) * 1992-12-30 1994-07-21 Glaxo Group Limited Benzanilide derivatives as 5-ht1d-antagonists
GB2276164A (en) * 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benzanilide derivatives
GB2276165A (en) * 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benzanilide compounds.
WO1994021619A1 (en) * 1993-03-16 1994-09-29 Pfizer Inc. Naphthalene derivatives
WO1995004729A1 (en) * 1993-08-06 1995-02-16 Smithkline Beecham Plc Amide derivatives as 5ht1d receptor antagonists
WO1995011243A1 (en) * 1993-10-19 1995-04-27 Smithkline Beecham Plc Benzanilide derivatives as 5ht-1d receptor antagonists
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
WO1995017888A1 (en) * 1993-12-30 1995-07-06 Smithkline Beecham Corporation Phenylmethyl hexanamides, and the use thereof

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533266A1 (en) * 1991-09-18 1993-03-24 Glaxo Group Limited Benzanilide derivatives as 5-HT1D antagonists
EP0533267A1 (en) * 1991-09-18 1993-03-24 Glaxo Group Limited Benzanilide derivatives as 5-HT1D antagonists
WO1994001556A1 (en) * 1992-07-01 1994-01-20 Institut National De La Sante Et De La Recherche Medicale (Inserm) Polypeptides having serotoninergic receptor activity (5ht6), nucleic acids coding for said polypeptides, and uses thereof
FR2699533A1 (en) * 1992-12-21 1994-06-24 Mouhtaram Mohamed N-2-piperazinyl 4-amino:benzamide derivs. having antiemetic and antipsychotic activity
GB2273930A (en) * 1992-12-30 1994-07-06 Glaxo Group Ltd Benzanilide derivatives
WO1994015920A1 (en) * 1992-12-30 1994-07-21 Glaxo Group Limited Benzanilide derivatives as 5-ht1d-antagonists
WO1994021619A1 (en) * 1993-03-16 1994-09-29 Pfizer Inc. Naphthalene derivatives
GB2276164A (en) * 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benzanilide derivatives
GB2276165A (en) * 1993-03-17 1994-09-21 Glaxo Group Ltd Aniline and benzanilide compounds.
WO1995004729A1 (en) * 1993-08-06 1995-02-16 Smithkline Beecham Plc Amide derivatives as 5ht1d receptor antagonists
WO1995011243A1 (en) * 1993-10-19 1995-04-27 Smithkline Beecham Plc Benzanilide derivatives as 5ht-1d receptor antagonists
EP0661266A1 (en) * 1993-12-27 1995-07-05 Toa Eiyo Ltd. Substituted cyclic amine compounds as 5HT2 antagonists
WO1995017888A1 (en) * 1993-12-30 1995-07-06 Smithkline Beecham Corporation Phenylmethyl hexanamides, and the use thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 100, no. 21, 21 May 1984, Columbus, Ohio, US; abstract no. 174780, XP002066493 *
CHEMICAL ABSTRACTS, vol. 121, no. 7, 15 August 1994, Columbus, Ohio, US; abstract no. 73080, XP002066494 *
DATABASE CHEM. ABS. REGISTRY American Chemical Society; *
J.W. CLITHEROW ET AL., JOURNAL OF MEDICINAL CHEMISTRY, vol. 37, no. 15, 1994, WASHINGTON US, pages 2253 - 2257 *
R. AGARWAL ET AL., INDIAN J. PHARMACOL., vol. 14, no. 2, 1982, pages 177 - 182 *

Also Published As

Publication number Publication date
CA2274055A1 (en) 1998-06-25
WO1998027058A2 (en) 1998-06-25
EP0946551A2 (en) 1999-10-06
JP2001506995A (en) 2001-05-29

Similar Documents

Publication Publication Date Title
HUP0000658A3 (en) Sulphonamide derivatives, process for their preparation, and their use as medicaments
ZA9711368B (en) Novel 2-flouroacrylic acid derivatives, novel mixtures of herbicides and antidotes, and their use.
AU1808595A (en) 3,8-diazabicyclo{3.2.1}octane derivatives having analgesic activity
AU2982295A (en) Oxidation catalyst, process for its preparation and oxidation process using said oxidation catalyst
AU5194999A (en) Benzothiepin derivatives, process for the preparation of the same and uses thereof
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU1231697A (en) Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof
HK1032958A1 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments.
ZA974574B (en) Novel guanidine derivatives process for their preparations and their use as pharmaceuticals.
WO1998027058A3 (en) N-piperazin-1-ylphenyl-benzamide derivatives
ZA966576B (en) Hydroximic acid derivatives, processes for their preparation, and compositions comprising them.
AU1504495A (en) Substituted heterocyclic carboxamidoesters, their preparation and their use as pharmaceuticals
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
AU6983494A (en) Indazolesulfonylurea derivative, use thereof, and intermediate for production thereof
HUP9602868A3 (en) 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
AU6282494A (en) 4-aminopyridines, their production and use as an antithrombosis agent
AU1140197A (en) Pyridyl carbamates, process and intermediates for the preparation and use thereof
AU2537695A (en) Epoxysuccinic acid derivatives, their production and use
ZA976329B (en) Substituted pyrazolylpyrazole derivatives, process for their preparation, and their use as herbicides.
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
AU2629995A (en) Novel quinolylamine derivative, process for production thereof, and use thereof as antiarrhythmic agent
AU692030B2 (en) Hydantoin derivatives, process for producing the same and herbicides comprising the same as active ingredients
AU3176497A (en) Catalyst for dehydrogenation of cyclohexanol, process for the preparation of said catalyst and use thereof
AU3785597A (en) Cyclic urea compounds, their production and use as herbicides
AU4845196A (en) 2-sulfinylnicotinamide derivatives, intermediate thereof, process for producing 2-sulfinylnicotinamide derivatives, and medicinal composition containing the same as active ingredient

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1997954435

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2274055

Country of ref document: CA

Ref country code: CA

Ref document number: 2274055

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 527348

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 09331353

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 1997954435

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997954435

Country of ref document: EP